Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK)
- PMID: 40229929
- DOI: 10.1111/bju.16739
Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK)
Abstract
Objective: To compare outcomes of nephrectomy for left-sided (n = 70) vs right-sided (n = 118) renal tumours with caval thrombi.
Methods: In this retrospective analysis (June 2008-February 2023), we evaluated peri-operative variables, 30-day complications, estimated glomerular filtration rate (eGFR), and survival rates.
Results: Patients in the left-sided renal tumour group experienced significantly longer operating times (240 vs 193 min; P < 0.001), greater blood loss (1700 vs 1000 mL, P = 0.042), and more complications (53% vs 35%, P = 0.015). Postoperative renal function was worse in the left-sided vs the right-sided renal tumour group, with lower immediate postoperative eGFR (P = 0.035) and a higher dialysis rate (17% vs 6.8%, P = 0.026). However, overall survival and recurrence-free survival were similar (P = 0.8 and P = 0.43, respectively).
Conclusions: Left-sided renal tumours with caval thrombi present a higher risk of complications and acute kidney injury requiring dialysis, potentially due to left renal vein ischaemia during surgery and anatomical proximity to the superior mesenteric artery. Thorough preoperative planning and limited clamping time are essential.
Keywords: haemodialysis; inferior vena cava thrombi; kidney cancer; laterality; locally advanced; outcomes.
© 2025 BJU International.
References
-
- Gu L, Peng C, Li H et al. Neoadjuvant therapy in renal cell carcinoma with tumor thrombus: a systematic review and meta‐analysis. Crit Rev Oncol Hematol 2024; 196: 104316
-
- Karam JA, Devine CE, Urbauer DL et al. Phase 2 trial of neoadjuvant Axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. Eur Urol 2014; 66: 874–880
-
- Ljungberg B, Albiges L, Abu‐Ghanem Y et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol 2022; 82: 399–410
-
- Ralla B, Adams L, Maxeiner A et al. Perioperative and oncologic outcome in patients treated for renal cell carcinoma with an extended inferior vena cava tumour thrombus level II–IV. Aktuelle Urol 2022; 53: 431–438
-
- González J, Gorin MA, Garcia‐Roig M, Ciancio G. Inferior vena cava resection and reconstruction: technical considerations in the surgical Management of Renal Cell Carcinoma with tumor thrombus. Urol Oncol 2014; 32: 34.e19–34.e26
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
